Not applicableStudy completedNCT03575260What this trial is testing500mg Fulvestrant Versus Exemestane in MBCWho this might be right forBreast Cancer Fudan University 120
Testing effectiveness (Phase 2)Ended earlyNCT02322853What this trial is testingTrial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE InhibitorsWho this might be right forPostmenopausalMetastatic Breast Cancer Centre Francois Baclesse 8
Not applicableUnknownNCT04891731What this trial is testingEfficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast CancerWho this might be right forHormone Receptor-positive Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Looking for participantsNCT01530373What this trial is testingSolifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsWho this might be right forHot FlashesBreast Cancer University of Arkansas 110
Post-approval studies (Phase 4)Study completedNCT05198141What this trial is testingEvaluation of Different Doses of Letrozole in Ectopic PregnancyWho this might be right forEctopic Pregnancy Zagazig University 60
Not applicableUnknownNCT05814224What this trial is testingMonitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNAWho this might be right forHormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more Centro di Riferimento Oncologico - Aviano 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944434What this trial is testingFACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast CancerWho this might be right forBreast Cancer Fondazione Sandro Pitigliani 116
Very early researchWithdrawnNCT04088032What this trial is testingNeoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast CancerWho this might be right forBreast Cancer FemaleLocally Advanced Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast Alison Stopeck
Post-approval studies (Phase 4)WithdrawnNCT03988114What this trial is testingAbemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Eli Lilly and Company
Testing effectiveness (Phase 2)UnknownNCT02689921What this trial is testingNEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast CancerWho this might be right forBreast Neoplasms Midwestern Regional Medical Center 7
Not applicableStudy completedNCT00809484What this trial is testingArimidex Bone Mass Index and Oral BisphosphonatesWho this might be right forBreast CancerBone Density Hellenic Breast Surgeons Society 220
Not applicableLooking for participantsNCT07295457What this trial is testingClinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)Who this might be right forBreast Cancer Hospices Civils de Lyon 182
Not applicableLooking for participantsNCT06534125What this trial is testingAcutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more Emory University 150
Testing effectiveness (Phase 2)Study completedNCT01797120What this trial is testingStudy of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AIWho this might be right forMetastatic Breast Cancer PrECOG, LLC. 131
Not applicableStudy completedNCT01050634What this trial is testingSequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)Who this might be right forPost Menopausal Women With Early Breast Cancer Pfizer 980
Post-approval studies (Phase 4)UnknownNCT03811509What this trial is testingBreast Cancer Women on Aromatase Inhibitors TreatmentWho this might be right forOsteoporosisOsteoporosis FractureArthralgia Generalized Parc de Salut Mar 1,000
Testing effectiveness (Phase 2)Study completedNCT00676663What this trial is testingStudy to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast CancerWho this might be right forBreast CancerEstrogen Receptor-Positive Breast CancerBreast Cancer, Estrogen Receptor-Positive+1 more Syndax Pharmaceuticals 130
Testing effectiveness (Phase 2)Study completedNCT01603303What this trial is testingPreventing Sexual Dysfunction With Aromatase InhibitorsWho this might be right forBreast Cancer M.D. Anderson Cancer Center 187
Testing effectiveness (Phase 2)Study completedNCT01129622What this trial is testingEffect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)Who this might be right forBreast Cancer Mount Sinai Hospital, Canada 16
Large-scale testing (Phase 3)Ended earlyNCT00908531What this trial is testingTrial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast CancerWho this might be right forOperable Breast Neoplasms Danish Breast Cancer Cooperative Group 123